How to sell digital health software to the NHS: a marketing guide for innovators
Many Digital Health innovators reach the same point: the product works, early users like it, and the question becomes how to sell it into the NHS. The honest answer is that there is no single front door. There are official routes, frameworks and evidence expectations, and there is the slower work of being credible and visible to the people who make decisions.
This guide looks at that journey from a marketing perspective. It points to the official sources innovators should read directly. It is not procurement, regulatory, DTAC or clinical safety advice, and those questions belong with specialists and the official guidance.
Start with the official routes
The NHS Innovation Service is a free online service from NHS England and partners that helps innovators understand what is needed to develop and sell an innovation in the NHS, and connects them with organisations that can support them. For most earlier-stage companies it is a sensible first stop.
NHS Supply Chain manages national frameworks used by NHS organisations to buy products and services, and its website explains how suppliers can engage with it.
Public contract opportunities are published on government platforms. Under the Procurement Act 2023, which came into force in February 2025, the Find a Tender service is the central digital platform for notices, and Contracts Finder continues to list lower-value opportunities in England. Reading notices in your area is useful market research even before you bid.
Understand the evidence buyers will ask for
NICE publishes the Evidence Standards Framework for digital health technologies, which sets out the kind of evidence expected for different types of product. Buyers and evaluators use frameworks like this to judge whether a technology is ready.
From a marketing point of view, the lesson is simple: your website and materials should make it easy to find what evidence exists, and should never claim more than it supports. Overstated claims are one of the fastest ways to lose trust with clinical and commissioning audiences.
Decisions involve many people
An NHS buying decision rarely sits with one person. Clinical leads, operational managers, digital and IT teams, information governance, finance and procurement can all have a say. Each will look at your organisation for different reasons.
Marketing that works here gives each of those people a clear answer to their own question: what problem it solves, how it fits existing pathways, what it costs to adopt, and what evidence sits behind it.
Be findable and credible before the first meeting
Most buyers will research you long before they reply to an email. A website that explains the product in plain language, a founder LinkedIn presence that shows genuine understanding of the sector, and a small number of useful articles all do quiet work in that period.
Consistency matters more than volume. A clear, accurate presence that is kept up to date signals an organisation that will still be there after the contract is signed.
Use regional innovation networks
Regional Health Innovation Networks across England support innovators to understand local needs and connect with NHS organisations. They are listed through the NHS Innovation Service. Being clear and well presented makes those introductions easier to turn into conversations.
Where marketing fits
Marketing cannot replace evidence, assurance or a good procurement response. What it can do is make sure that when the right people look, they quickly understand what you do, why it matters and why you are credible. For earlier-stage innovators, that foundation is what the Clarity Innovator Pack is built to provide.
This article refers to a position current at the date above and is reviewed when the underlying guidance or policy changes. Clarity Media Co. comments on the marketing and commercial implications of developments in Digital Health and HealthTech. We do not provide clinical, regulatory, DTAC or legal advice.